Description

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic analogue of growth hormone-releasing hormone (GHRH) designed to support the body’s natural production of growth hormone. By binding to albumin through the Drug Affinity Complex, this formulation has an extended half-life compared with standard GHRH peptides, allowing for sustained activity and reduced dosing frequency.

This long-acting peptide is commonly researched for its potential role in promoting growth hormone release, which may contribute to improvements in muscle development, recovery, metabolic function, and overall physiological repair processes. Its extended duration of action makes it a convenient option for protocols that require consistent stimulation of endogenous growth hormone pathways.

Key Benefits:
Promotes natural growth hormone release
Supports muscle growth and recovery
May improve fat metabolism and body composition
Encourages better sleep and cellular repair
Long-acting formula for convenient use